Different types of contraceptive drugs and devices or birth control methods have large differences in effectiveness, actions required of users, and side effects. The effective contraceptive methods of birth control include intrauterine and implantable birth control devices followed by a number of hormone based methods including oral pills, patches, vaginal rings, and injections. These devices also prevent spreading of sexually transmitted infection. Some of the products such as male condoms and female condoms also help in preventing sexually transmitted infections. Other methods include physical barriers such as condoms, diaphragms and birth control sponges.
The global contraceptive drugs and devices market report estimates the market size (Revenue US$ million – 2014 to 2021) for key market segments based on the drug type (oral, injectable and topical drugs), device type (diaphragms, sponges, vaginal rings, male and female condoms, intrauterine, non-surgical and sub-dermal devices and implants), and forecasts growth trends (CAGR% – 2017 to 2021).
The global contraceptive drugs and devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global contraceptive drugs and devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global contraceptive drugs and devices market and included in this report are Actavis, Inc., Bayers AG, Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and The Female Health Company.